Resources

Type of publications
Regions
Diseases
5113 results found
2022 ∙ Salari, N. Vepa, A. Daneshkhah, A. Darvishi, N. Ghasemi, H. Khunti, K. Mohammadi, M.
Efficacy of COVID-19 vaccines by race and ethnicity
All age groups COVID-19 Efficacy/effectiveness Ethical issues Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Lee, A. R. Y. B. Wong, S. Y. Chai, L. Y. A. Lee, S. C. Lee, M. X. Muthiah, M. D. Tay, S. H. Teo, C. B. Tan, B. K. J. Chan, Y. H. Sundar, R. Soon, Y. Y.
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Kumar, S. Saikia, D. Bankar, M. Saurabh, M. K. Singh, H. Varikasuvu, S. R. Maharshi, V.
Efficacy of COVID-19 vaccines: a systematic review and network meta-analysis of phase 3 randomized controlled trials
Adults Older adults COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ren, X. Hao, Y. Wu, B. Jia, X. Niu, M. Wang, K. Li, Z.
Efficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: A meta-analysis
South-East Asia Western Pacific Adolescents Adults Human papillomavirus (HPV) Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Xia, Y. Zhang, X. Zhang, L. Fu, C.
Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis
Adults Older adults Herpes zoster Safety Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Li, Z. Liu, S. Li, F. Li, Y. Li, Y. Peng, P. Li, S. He, L. Liu, T.
Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Jansen, M. H. Rondaan, C. Legger, G. Minden, K. Uziel, Y. Toplak, N. Maritsi, D. van den Berg, M. Berbers, G. Bruijning, P. Egert, Y. Normand, C. Bijl, M. Foster, H. Kone-Paut, I. Wouters, C. Ravelli, A. Elkayam, O. Wulffraat, N. M. Heijstek, M. W.
Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations
Newborn Children Adolescents Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Lenzing, E. Rezahosseini, O. Burgdorf, S. K. Nielsen, S. D. Harboe, Z. B.
Efficacy, immunogenicity, and evidence for best-timing of pneumococcal vaccination in splenectomized adults: a systematic review
Adults Older adults Pneumococcal disease Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Oh, S. Purja, S. Shin, H. Kim, M. S. Park, S. Kronbichler, A. Smith, L. Eisenhut, M. Shin, J. I. Kim, E.
Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Randomized Control Trials in the Pre-Delta Era: A Systematic Review and Network Meta-Analysis
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Parker, E. P. K. Desai, S. Marti, M. O'Brien, K. L. Kaslow, D. C. Kochhar, S. Olayinka, F. Cravioto, A. Nohynek, H. Hombach, J. Wilder-Smith, A.
Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix?
All age groups COVID-19 Safety Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...